Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Deep Brain Stimulation In Parkinson`s Disease Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The market for deep brain stimulation in Parkinson’s disease has experienced strong growth in recent years. It is forecast to grow from $3.27 billion in 2025 to $3.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. The expansion observed in prior periods can be attributed to the rising occurrence of Parkinson’s disease, increased adoption of DBS devices, enhanced awareness of advanced neuromodulation therapies, the development of neurosurgical infrastructure, and growing healthcare spending.
The deep brain stimulation in parkinson’s disease market size is poised for robust expansion in the upcoming years. It is forecast to grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. This anticipated growth throughout the forecast period can be attributed to several factors: a rising demand for tailored neuromodulation therapies, increased investments in research and clinical trials, enhanced access to tele-neurology services, expanded reimbursement coverage, and a greater adoption of MRI-compatible and rechargeable devices. Significant trends expected during this period include technological advancements in closed-loop and directional stimulation, innovations in rechargeable and long-life IPGs, progress in AI-assisted DBS programming, continuous research and development in minimally invasive surgical techniques, and advancements in remote monitoring and telemedicine functionalities.
Get A Free Sample Report With In-Depth Market Insights:
Deep Brain Stimulation In Parkinson`s Disease Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing population of individuals diagnosed with Parkinson’s disease is projected to stimulate expansion within the deep brain stimulation in Parkinson’s disease market. Parkinson’s disease, a progressive neurological condition, impairs movement through symptoms such as tremors, rigidity, slowed motion, and balance issues, stemming from the deterioration of dopamine-producing neurons in the brain. The increase in Parkinson’s disease patient numbers is linked to an aging demographic, as the likelihood of developing the condition significantly escalates with advancing age. Deep brain stimulation offers a management strategy for Parkinson’s disease by delivering precise electrical impulses to specific brain areas, thereby alleviating motor symptoms, enhancing patients’ quality of life, and lessening reliance on long-term medications. For example, the Parkinson’s Foundation, a US-based non-profit organization, estimated that in 2025, approximately 1.1 million people in the United States are living with Parkinson’s disease, a figure expected to climb to 1.2 million by 2030, with almost 90,000 new diagnoses each year and more than 10 million people affected worldwide. Consequently, the growing prevalence of Parkinson’s disease patients is a key driver for the growth of the deep brain stimulation in Parkinson’s disease market.
Deep Brain Stimulation In Parkinson`s Disease Market Segmentation: How Does The Market Break Down By Category?
The deep brain stimulation in parkinson`s disease market covered in this report is segmented –
1) By Product Type: Implantable Pulse Generators (IPGs), Electrodes And Leads, External Programmers, Accessories And Consumables
2) By Technology: Conventional Deep Brain Stimulation (DBS) Systems, Closed Loop Deep Brain Stimulation (DBS) Systems, Wireless Deep Brain Stimulation (DBS) Systems
3) By Service Type: Pre-Surgical Evaluation Services, Surgical Implantation Services, Device Programming Services, Patient Monitoring Services, Maintenance And Follow-Up Services, Rehabilitation Support Services, Tele-Neurology Support Services, Training And Education Services
4) By Application: Tremor Management, Rigidity And Stiffness Management, Bradykinesia (Slow Movement) Management, Dyskinesia Management
5) By End-Users: Hospitals, Ambulatory Surgical Centres, Neurology Clinics
Subsegments:
1) By Implantable Pulse Generators (IPGs): Rechargeable Implantable Pulse Generators, Non-Rechargeable Implantable Pulse Generators, Directional Implantable Pulse Generators
2) By Electrodes And Leads: Cylindrical Electrodes, Directional Electrodes, Stimulation Leads
3) By External Programmers: Handheld External Programmers, Desktop External Programmers, Wireless External Programmers
4) By Accessories And Consumables: Extension Cables, Battery Chargers, Surgical Tool Kits
#Deep Brain Stimulation In Parkinson`s Disease Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the deep brain stimulation in Parkinson’s disease market are concentrating on developing sophisticated products, including miniaturized rechargeable implantable pulse generators and integrated remote programming platforms, to enhance patient comfort and access to care. Miniaturizing rechargeable implantable pulse generators involves crafting these battery-powered neurostimulation devices into much smaller, thinner forms, allowing for less invasive implantation while still delivering consistent therapeutic electrical pulses over extended durations. For instance, in January 2024, Abbott Laboratories, a US-based multinational medical devices and healthcare company, launched its Liberta RC DBS system. This platform is a miniaturized rechargeable deep brain stimulation system featuring remote programming capabilities, designed to treat individuals living with movement disorders such as Parkinson’s disease and essential tremor. Furthermore, this solution offers the longest recharge interval of any FDA-approved DBS system, requiring only 10 recharge sessions a year for most people, and utilizes the NeuroSphere Virtual Clinic to enable patients to communicate with their doctors and receive treatment adjustments from the convenience of their homes.
Deep Brain Stimulation In Parkinson`s Disease Market Leading Players And Competitive Positioning
Major companies operating in the deep brain stimulation in parkinson`s disease market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Mayo Foundation for Medical Education and Research, Cleveland Clinic, Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., BrainGate Company Inc.
View The Full Deep Brain Stimulation In Parkinson`s Disease Market Report:
Deep Brain Stimulation In Parkinson`s Disease Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the deep brain stimulation in parkinson’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation in parkinson`s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
